ODMachine
ODMachine is an Israeli healthcare AI company that builds an AI-powered big data platform for analyzing genomic, imaging, and clinical data, delivering products such as Health Compass, Optima Stroke, and ODMEcho to governments, hospitals, insurers, and pharmaceutical companies via subscription enterprise contracts.
- Company typePrivate
- Founded2020
- HeadquartersHerzliya, Israel
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What ODMachine does
ODMachine (ODM) is a privately held Israeli healthcare technology company that develops an AI-powered big data platform for the collection, normalization, and analysis of biomedical data across genomic, imaging, and clinical record formats. The company's core technology uses machine learning, deep learning (including convolutional neural networks), and large-scale data mining to transform raw multi-source medical data into predictive and actionable insights. Its product portfolio is anchored on a unified platform supporting several applications: Health Compass (population health monitoring and personalized preventive medicine), Optima Stroke (stroke risk prediction via carotid calcification detection in dental panoramic X-rays, with 87% recall and 97% specificity), ODMEcho (AI-augmented echocardiogram analysis), Therapeutic Roadmaps and Future Health (personalized treatment and testing recommendations), Research Roadmaps (B2B research tooling), and disease/population health modules aligned to national healthcare strategies.
ODM serves enterprise and public-sector buyers across four primary verticals: government health ministries and national healthcare systems (Morocco, Kazakhstan, Israel engagements), medical centers and hospitals (Poriya, Kaplan, Hadassah-affiliated), health insurers, and pharmaceutical companies, with a secondary segment of research institutes and B2C physicians/patients. The company operates an enterprise field-sales go-to-market supplemented by telemedicine service provider channels (for Health Compass distribution), dental clinic networks (for Optima Stroke), and clinical trial partnerships for product validation. Revenue is structured predominantly around recurring subscription access to its analytics platform and products, supplemented by clinical trial professional services. Pricing is not publicly disclosed and is negotiated through bespoke enterprise agreements.
Founded in 2018 and headquartered in Herzliya Pituach with an R&D office at the Hadassah Medical Center BIOHOUSE in Jerusalem, ODM has 101-250 employees, an interdisciplinary leadership team spanning former IDF technical talent, Hebrew University/Weizmann graduates, and senior medical figures including Prof. Roberto Lang (University of Chicago Medicine) and former Teva Israel CEO Ron Mayron. The company has no disclosed institutional funding rounds, operating geographies currently span Israel, Morocco, and Kazakhstan, and the most recent public activity (Feb 2025) signals U.S. market intent.
ODMachine firmographics
Firmographics- Name
- ODMachine
- Legal name
- Odmachine Ltd.
- Website
- https://odmachine.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- ODMachine is an Israeli healthcare AI company that builds an AI-powered big data platform for analyzing genomic, imaging, and clinical data, delivering products such as Health Compass, Optima Stroke, and ODMEcho to governments, hospitals, insurers, and pharmaceutical companies via subscription enterprise contracts.
- Ownership category
- akta.pro rank
ODMachine industry classification
Industry- Product category
- Healthcare AI / Clinical Decision Support Software
- NAICS
- Software Publishers (5132), Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Medication Analytics, Outcomes & Cost Optimization (HLACAKAL)
- akta.pro secondary industry
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)
Keywords
Where ODMachine is headquartered
LocationHeadquarters
- HQ city
- Herzliya
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
ODMachine business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Healthcare AI Platform Services: Subscription-based access to AI-powered healthcare data analytics platform providing disease management, predictive modeling, and actionable insights to healthcare organizations.
- Health Compass Preventive Medicine: Personalized preventive medicine service delivered through telemedicine providers to health insurers and national organizations, providing ongoing health monitoring and recommendations.
- Optima Stroke Product: AI-powered stroke risk detection service implemented through dental clinics, analyzing panoramic X-rays for carotid calcification detection.
- Clinical Trial Services: Collaboration with medical centers for product development and clinical verification of AI diagnostic tools.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
ODMachine product offering
Product offeringCore offering
ODMachine sells an AI-powered healthcare big data platform that ingests clinical records, genomic sequences (DNA/RNA), protein data, medical imaging, and pharmaceutical data, normalizing them into a uniform format for actionable insights. The platform powers multiple products including Health Compass (population health and preventive medicine), Optima Stroke (stroke risk prediction from dental X-rays), ODMEcho (echocardiogram analysis), Therapeutic Roadmaps, Research Roadmaps, and Future Health. It is sold primarily through enterprise agreements to healthcare providers, ministries of health, insurers, pharmaceutical firms, and research institutes.
Product overview
ODMachine (ODM) offers an AI-powered healthcare big data platform with multiple integrated products and modules. The core platform (ODM Healthcare Platform) normalizes, analyzes, and makes healthcare data actionable. The product portfolio includes Health Compass (population health monitoring and preventive medicine), Optima Stroke (stroke risk prediction from dental X-rays), ODMEcho (echocardiogram analysis), Therapeutic Roadmaps (B2C treatment recommendations), and Research Roadmaps (B2B research platform). These products work together on the unified platform to enable disease prediction, prevention, and personalized medicine across healthcare organizations.
Differentiator
Problem solved
Functional benefit
Brands
- Health Compass: Comprehensive analytics platform for monitoring population health and driving informed care decisions through personalized preventive medicine.
- Optima Stroke
- ODMEcho
- Future Health
- Therapeutic Roadmaps
- Research Roadmaps
Products and services
- ODM Healthcare Platform (Core) AI-powered big data platform that transforms raw healthcare data (clinical records, genomic data, medical images, pharmaceutical data) into actionable insights via normalization, visualization, and analytics for healthcare providers.
- Health Compass Comprehensive analytics platform for population health monitoring and personalized preventive medicine, analyzing medical history and health behaviors to deliver targeted testing recommendations and enable early disease detection for health insurers and national organizations.
- Optima Stroke AI-powered product that predicts stroke risk by detecting calcification in carotid arteries through analysis of standard panoramic dental X-rays, using deep learning convolutional neural networks with 87% recall and 97% specificity for dental and primary care settings.
- Therapeutic Roadmaps B2C product that builds patient clinical profiles from uploaded medical data, prepares disease treatment pathways, recommends and prioritizes possible treatments, and learns from similar cases for physicians.
- Research Roadmaps B2B product offering capabilities and services to academic institutes and commercial organizations for research purposes, enabling efficient mining of biological big data.
- Future Health Personalized preventive medicine product delivering automated service with precise, personalized testing recommendations based on analysis of all data in a patient's medical file, targeting health plan members.
- ODMEcho AI-augmented, automatic, cloud-based product for physicians to analyze echocardiograms, reducing variability among echocardiographers, improving detection accuracy, and decreasing acquisition time.
Quantifiable outcome
- Stroke prediction with 87% Recall (True Positive) and 97% Specificity (True Negative) using panoramic dental X-rays
- +3 more outcomes
Companies that use ODMachine
Customer profileNamed customers7 records
Segments6 records
Ideal customer profiles4 records
ODMachine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature9 records
ODMachine partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core.
- Moroccan Ministry of HealthcoreODM presented Health Compass preventive medicine service to Moroccan Ministry of Health officials including Mr. Hicham Rahil (Director) and Mr. Abdelkader Mhayi (Head of Information). ODM has begun selecting a local operator to implement Health Compass in Morocco for personalized preventive medicine services and early disease detection.
- FEMI (IDF Organization for Disabled Veterans)coreODM and FEMI are collaborating to provide members of the IDF Organization for Disabled Veterans with Health Compass preventive medicine service. Starting April 2023, members receive customized personalized preventive medicine services using state-of-the-art algorithms to identify potential health issues before they become serious, enabling early intervention.
- Kazakhstan Ministry of HealthcoreODM representatives met with Kazakhstan Minister of Health Azhar Giniyat to discuss implementation of AI platform in National Research Oncology Center together with Kazakh Research Institute of Oncology and Radiology. Meeting follows September 2022 MoU signed between Kazakhstan and Israel Ministry of Health.
- National Research Oncology Center (Kazakhstan)coreODM delegation led by Vice Chairman met with management to present National Digital Oncology Platform for enhancing oncology healthcare and decreasing mortality using AI.
- Moroccan Ministry of HealthcoreFollow-up meeting in Rabat with Moroccan Ministry of Health representatives discussing implementation stages for ODM platform in Moroccan healthcare system. Prof. Avi Porath presented data modeling capabilities for National Disease Management Strategy.
- Prof. Roberto LangcoreProf. Roberto Lang joined as part of ODM's team of medical directors. Internationally renowned cardiologist and echocardiography specialist, past president of American Society of Echocardiography, currently at University of Chicago Medicine.
- KSM Maccabi Research and Innovation CentercoreCollaboration on big data study examining connection between panoramic dental images and early diagnosis of osteoporosis. Research uses AI and machine learning on de-identified data to detect early signs of bone weakness. KSM provides research platform with online de-identified databases and epidemiological capabilities.
- Maccabi DentcoreMaccabi Dent (56 dental clinics) participating in osteoporosis detection study providing de-identified panoramic dental images. Partnership leverages Maccabi's computerized documentation for groundbreaking research using ODM's AI platform.
- Prof. Avi PorathcoreProf. Avi Porath joined as Medical Director of Future Health product, bringing expertise in quality assurance in medicine and healthcare services. Previously CMO at Maccabi Healthcare Services and Head of Internal Medicine at Soroka Medical Center.
- Kaplan Medical CentercoreClinical trial agreement for Optima Stroke product under direction of Dr. Sagi Tshori (Chairman of Kaplan Hospital Research Authority). Prospective clinical trial to validate AI-based stroke prediction using carotid artery disease detection.
- Poriya Medical CentercoreClinical Trial Agreement for developing and verifying Optima Stroke product using AI platform to predict stroke risk from panoramic dental X-rays. Helsinki Committee approved trial in May 2021. Prof. Imad Abu El-Naaj serves as principal investigator.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
ODMachine competitors and assessment
Company assessmentDirect peers
- Viz.ai: U.S.-based AI platform specializing in stroke and neurovascular care, using deep learning on imaging to triage and coordinate stroke patients. Directly comparable to ODM's Optima Stroke, which similarly applies deep learning to predict stroke risk — Viz.ai works on brain imaging, ODM on dental X-rays, but both target the same stroke-care workflow with validated AI.
- Aidoc: Israeli-founded AI medical imaging company providing deep-learning-based analysis for CT, MRI and X-ray across multiple clinical conditions. Comparable to ODM on multimodal imaging AI (dental X-ray, echocardiograms, CT/MRI) and on founder depth from Israeli technical universities and IDF alumni, serving similar hospital and enterprise healthcare buyers.
- Nanox (Zebra Medical Vision): Israeli-founded AI medical imaging company (now part of Nanox) that uses deep learning to detect findings across imaging modalities. Highly comparable to ODM as another Israeli AI imaging platform pursuing enterprise healthcare contracts at population scale.
- HeartFlow: U.S. company applying AI to cardiovascular imaging (FFR-CT) for diagnostic decision support. Closely comparable to ODM's ODMEcho, which applies AI to echocardiograms with a similar goal of standardizing and improving cardiovascular diagnosis.
- Syapse: U.S. precision oncology company that integrates multi-source real-world patient data for providers and pharma. Comparable to ODM's platform architecture for normalized, multi-source data integration across clinical, genomic, and imaging datasets.
Broad incumbents
- Tempus Labs: U.S. AI-driven precision medicine company that aggregates clinical and molecular data (including sequencing and imaging) to enable research and therapy selection. Comparable to ODM's cross-domain data platform approach (DNA/RNA, clinical, imaging), though Tempus is broader and oncology-focused, and is far more mature and capitalized.
- Health Catalyst: U.S. healthcare data and analytics enterprise platform serving hospitals, health systems, and payers for population health, outcomes and cost improvement. Comparable to ODM's Health Compass in serving health systems and insurers for population health management and cost optimization.
Emerging players
- DreaMed Diabetes: Israeli med-tech focused on AI-driven decision support for diabetes management. Comparable to ODM's emphasis on chronic disease (diabetes, hypertension) with AI-driven monitoring and outcomes improvement, and shares the Israeli origin.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
ODMachine social profiles
Digital presenceODMachine financial estimates
Financial estimateRevenue estimate
Valuation estimate
ODMachine leadership team
Management profileNumber of profiles
Profiles8 records
ODMachine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ODMachine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ODMachine
What does ODMachine do?
ODMachine sells an AI-powered healthcare big data platform that ingests clinical records, genomic sequences (DNA/RNA), protein data, medical imaging, and pharmaceutical data, normalizing them into a uniform format for actionable insights. The platform powers multiple products including Health Compass (population health and preventive medicine), Optima Stroke (stroke risk prediction from dental X-rays), ODMEcho (echocardiogram analysis), Therapeutic Roadmaps, Research Roadmaps, and Future Health. It is sold primarily through enterprise agreements to healthcare providers, ministries of health, insurers, pharmaceutical firms, and research institutes.
Is ODMachine a public or private company?
ODMachine is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ODMachine founded?
ODMachine was founded in 2020. It employs 101 to 250 people.
Where is ODMachine based?
ODMachine is headquartered in Herzliya, Israel, in the Middle East region.
How does ODMachine make money?
Four revenue lines are on record. Healthcare AI Platform Services are the primary driver. The others are health Compass Preventive Medicine, optima Stroke Product and clinical Trial Services.
Who are ODMachine's main competitors?
Direct peers on record are Viz.ai, Aidoc, Nanox (Zebra Medical Vision), HeartFlow and Syapse. Broad incumbents are Tempus Labs and Health Catalyst. DreaMed Diabetes is listed as an emerging player.
Does ODMachine have an API?
No public API is recorded for ODMachine.
What industry is ODMachine in?
ODMachine's product category is Healthcare AI / Clinical Decision Support Software. Its primary akta.pro industry code is HLACAKAL, Medication Analytics, Outcomes & Cost Optimization, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 5132 and its SIC code is 8000.